Top 10 Educational Resources of 2021
The year 2021 brought many advancements in the clinical research industry. We’ve pushed for more diversity and inclusion in clinical
The year 2021 brought many advancements in the clinical research industry. We’ve pushed for more diversity and inclusion in clinical
Phase I oncology trials present distinct ethical challenges, such as participant vulnerability and the risk of therapeutic misconception, requiring careful oversight.
As March 2020 completely disrupted any sense of normalcy, including in the workplace, many were forced to adapt rather quickly.
As a research site starts the adoption and implementation process for a new technology, there are several moving parts. Sites
Since early 2020, clinical research sites – like many industries – experienced profound COVID-19 impacts. Specifically, sites had to maneuver
As the COVID-19 pandemic has forced a shift toward remote modalities, mobile health (mHealth) technologies have been on the rise.
The discussion on decentralized clinical trials (DCTs) has been brought to the forefront in the wake of the COVID-19 pandemic.
Gene therapy research is highly regulated due to associated risks, often leading to confusion among professionals new to its regulatory requirements.
Key ROI metrics—like publications, staff impact, and core contributions—provide insight into research value and support institutional growth.
Patient-centric trial design, combined with eConsent, fosters better communication, comprehension, and retention, ensuring a smoother, more informed journey.
During the week of October 5-8, more than 1,700 Advarra technology customers gathered virtually for the Fall Onsemble Conference. A
More often than not, researchers face screen failures during the study activation process. Screen failures occur when research staff put